ImmuCell
ICCC
25 hedge funds and large institutions have $4.31M invested in ImmuCell in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
11% more capital invested
Capital invested by funds: $3.88M → $4.31M (+$433K)
0.13% more ownership
Funds ownership: 9.91% → 10.04% (+0.13%)
7% less funds holding
Funds holding: 27 → 25 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$70.1K |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$65.2K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$20.4K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$7.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFS
Essex Financial Services
Essex,
Connecticut
|
-$109K |
| 2 |
HPC
HM Payson & Co
Portland,
Maine
|
-$52.4K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$29.1K |
| 4 |
Citigroup
New York
|
-$5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$728 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citigroup
New York
| – | -$5K | -930 | Closed |
|
ICCC Hedge Fund Activity: Q4 2020 in Review
25 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2020, worth a combined $4.31M — up 11% from $3.88M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ICCC and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $70.1K. The largest seller was Essex Financial Services, exiting entirely with an estimated $109K sold.
- 25 institutional investors held ImmuCell (ICCC) as of Q4 2020, down from 27 in Q3 2020.
- Funds reported $4.31M of ImmuCell stock for Q4 2020, up 11% quarter-over-quarter.
- 2 funds opened new ImmuCell positions in Q4 2020 and 4 closed out, a net change of -2 holders.
- The largest ImmuCell buyer in Q4 2020 was Renaissance Technologies, an estimated $70.1K added.
- The largest ImmuCell seller in Q4 2020 was Essex Financial Services, an estimated $109K sold.
Based on aggregated 13F filings for Q4 2020.